Danazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human Monocytes
article
OA: closed
CC0
⤵ 32 in-corpus citations
AI-generated summary
Danazol dose-dependently suppressed interleukin-1β and tumor necrosis factor production by human monocytes, while estradiol and progesterone only enhanced it in some donors.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ABSTRACT: The effects of estradiol (E 2 ), progesterone (P), and danazol on the production of interleukin‐1β (IL‐1β) and tumor necrosis factor (TNF) by OK‐432 (a streptococcal preparation)‐stimulated monocytes were examined. E 2 and P at physiologic concentrations enhanced IL‐1β and TNF production by monocytes from donors with lower control levels (without steroids added) of IL‐1β and TNF. However, E 2 and P at physiologic concentrations did not affect IL‐1β and TNF production by monocytes from donors with higher control levels of IL‐1β and TNF. Danazol inhibited IL‐1β and TNF production by monocytes in a dose‐dependent manner from not only donors with lower control levels of IL‐1β and TNF but also donors with higher control levels of IL‐1β and TNF. Danazol at a concentration of 10 −6 M significantly suppressed IL‐1β and TNF production in the presence of E 2 and/or P at concentrations giving peak responses of IL‐1β production. These findings suggest possible new mechanisms of action for danazol in the treatment of endometriosis and infertility associated with immune abnormalities.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Immunologic Aspects of Endometriosis via openalex
- Immunosuppressive effects of danazol in vitro via openalex
- Inhibition of Adrenal Steroidogenesis by Danazol in Vivo via openalex
- Interleukin-1: a possible role in the infertility associated with endometriosis via openalex
- Interleukin‐1: A possible role in the infertility associated with endometriosis via openalex
- Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement. via openalex
- doi:10.1016/s0015-0282(16)59945-2 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.1126/science.3871252 via openalex
- doi:10.3109/08923978909082141 via openalex
- W249118332 via openalex
- doi:10.1038/326330a0 via openalex
- doi:10.1172/jci113301 via openalex
- doi:10.1126/science.3754653 via openalex
- doi:10.1016/0167-5699(90)90088-q via openalex
- W2468865237 via openalex
- doi:10.1084/jem.166.3.786 via openalex
- doi:10.1084/jem.147.6.1684 via openalex
- doi:10.1016/s0015-0282(16)59056-6 via openalex
- doi:10.1002/eji.1830171224 via openalex
- doi:10.1016/0020-7292(89)90287-7 via openalex
- doi:10.4049/jimmunol.139.7.2250 via openalex
- doi:10.1016/s0015-0282(16)60185-1 via openalex
- doi:10.1056/nejm198306093082306 via openalex
- doi:10.1016/0002-9378(89)90179-8 via openalex
Cited by (26)
- Immunotherapy: A promising novel endometriosis therapy 2023
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- The Role of Oxidative Stress in Endometriosis 2015
- Effects of Danazol on Clinical Improvement of Patients with Human T-cell Lymphotropic Virus Type I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Placebo-Controlled Clinical Trial. 2013
- Oxidative Stress and its Role in Endometriosis—Mechanistic and Therapeutic Implications 2012
- Danazol induces prolonged survival of fully allogeneic cardiac grafts and maintains the generation of regulatory CD4+ cells in mice 2012
- Danazol therapy for aplastic anemia refractory to immunosuppressive therapy 2007
- Role of oxidative stress in endometriosis 2006
- Novel targets for the treatment of endometriosis 2004
- In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis 2004
- Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas 2003
- Potential involvement of the immune system in the development of endometriosis 2003
- Immunology of Endometriosis and Immunotherapy 2003
- Medical Management of Endometriosis: Novel Targets and Approaches towards the Development of Future Treatment Regimes 2003
- Treating endometriosis as an autoimmune disease 2001
- Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis 2000
- Is adenomyosis an immune disease? 1998
- Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: a multicenter cooperative study 1996
- Changes in bone mineral content following hormone treatment for endometriosis 1995
- Danazol decreases transcription of estrogen receptor gene in human monocytes 1995
- Endometriosis: Immune Cells and Their Products 1994
- A review of 76 patients with myelodysplastic syndromes treated with danazol 1994
- Gestrinone inhibits macrophage function and mitogen-stimulated lymphocyte proliferation in vitro 1994
- Immunosuppressive effect of danazol on lymphocyte-mediated cytotoxicity toward human endometrial stromal cells 1994
- Hormone Treatment Related Bone Mineral Content Changes in Japanese Women with Endometriosis 1993
- Danazol Suppresses Both Spontaneous and Activated Human Lymphocyte‐Mediated Cytotoxicity 1992
Source provenance
- europepmc
- last seen: 2026-09-05T06:14:40.014199+00:00
- openalex
- last seen: 2026-05-11T04:14:47.368170+00:00
- pubmed
- last seen: 2026-05-13T22:12:05.481982+00:00
- unpaywall
- last seen: 2026-09-05T06:29:56.012541+00:00
License: CC0
· commercial use OK